Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of 25 mg DKP.TRIS given as an
Enantyum® oral solution (Test formulation) and Keral® tablet (Reference formulation). In
addition, this study intends to evaluate the safety and tolerability of Test and Reference
formulations.